Bmc Endocrine Disorders
Overview
BMC Endocrine Disorders is a peer-reviewed open-access journal that publishes high-quality research on all aspects of endocrine disorders. It covers a wide range of topics including diabetes, thyroid disorders, adrenal disorders, pituitary disorders, and reproductive endocrinology. The journal aims to advance knowledge and understanding in the field by providing a platform for researchers, clinicians, and healthcare professionals to share their findings and insights.
Details
Details
Abbr.
BMC Endocr Disord
Publisher
Biomed Central
Start
2001
End
Continuing
e-ISSN
1472-6823
Country
United Kingdom
Language
English
Specialty
Endocrinology
Metrics
Metrics
h-index / Ranks: 6339
58
SJR / Ranks: 5384
789
CiteScore / Ranks: 6699
4.00
JIF / Ranks: 3958
2.7
Recent Articles
11.
Jannatalipour A, Panahi N, Pejman Sani M, Ghaemi O, Kheirandish M, Alipour N, et al.
BMC Endocr Disord
. 2025 Mar;
25(1):59.
PMID: 40045285
Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome caused by the secretion of high molecular weight insulin-like growth factor II (IGF-II) from tumors, particularly those of mesenchymal and...
12.
El-Gendy O, Alsafi W, Al-Shafei K, Hassan A, Adam I
BMC Endocr Disord
. 2025 Mar;
25(1):58.
PMID: 40025528
Introduction: The global increase of prediabetes and diabetes in adolescents raises the issue of early prediction of this metabolic disorder via anthropometric parameters, especially in limited resources settings such as...
13.
Lu J, Wei F, Sun J, Zhai Z, Pan J, Huang S, et al.
BMC Endocr Disord
. 2025 Feb;
25(1):57.
PMID: 40016771
Purpose: Hip fracture is the most dangerous and potentially lethal fracture, described as "the last fracture of life" in older adults. Previous studies have shown that excessive immunoinflammatory response and...
14.
Alanazi M, Alshehri K, Alerwy F, Alrasheed T, Lahza H, Aref Albezrah N, et al.
BMC Endocr Disord
. 2025 Feb;
25(1):56.
PMID: 40016702
Objectives: Central obesity is a well-known risk factor of numerous disease. Numerous indicators are developed for central obesity measurement, among them, abdominal volume index (AVI), reflecting total volume of the...
15.
Al-Rawaf H, Gabr S, Alghadir T, Alghadir F, Iqbal A, Alghadir A
BMC Endocr Disord
. 2025 Feb;
25(1):55.
PMID: 40016689
Background: This research investigated how physical activity (PA) might impact the expression of several microRNAs, specifically miR-126, miR-146a, miR-34a, miR-124a, miR-155, and miR-221, in the blood of elderly individuals with...
16.
Ebeid A, Mokhtar F, Martinez-Lebron V, Park S, Degann S, Payano J, et al.
BMC Endocr Disord
. 2025 Feb;
25(1):53.
PMID: 40011894
Background: Metabolic dysfunction associated steatotic liver disease (MASLD) is prevalent in up to 60% of patients with type 2 diabetes mellitus (T2DM). T2DM accelerates the risk of hepatic fibrosis and...
17.
Zhou X, Wu R, Tang G, Shen T, Li W
BMC Endocr Disord
. 2025 Feb;
25(1):54.
PMID: 40011864
Background: Obesity will cause metabolic syndrome (Mets) easily, and its pathogenesis is not completely clear. Aim: To probe into the predictive value of miR-122-5p and its regulatory mechanism in Mets....
18.
Shojaei F, Erfanifar A, Kalbasi S, Nikpour S, Gachkar L
BMC Endocr Disord
. 2025 Feb;
25(1):52.
PMID: 40011855
Background And Objective: The effects of Empagliflozin on liver health in patients with Type 2 Diabetes Mellitus (T2DM) have not been fully elucidated. This study aimed to assess the impact...
19.
Hou S, Wang Y, Wei Z, Li H, Fang H, Zhang T, et al.
BMC Endocr Disord
. 2025 Feb;
25(1):51.
PMID: 39994754
No abstract available.
20.
Yuan R, Zhang Y, Han J
BMC Endocr Disord
. 2025 Feb;
25(1):49.
PMID: 39994710
Background: Selenium is a key regulator of metabolic homeostasis. It has been proposed that exposure to selenium might be associated with metabolic syndrome (MetS). However, the results are contradictory. This...